Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

acquisition of Bioenvision,

Inc. in October 2007 and $(552,900)K related to our acquisition of

AnorMED Inc. in November 2006.

(6) Represents the write off of the goodwill related to our Genetics

reporting unit in September 2006 in accordance with FAS 142,

"Goodwill and Other Intangible Assets."

(7) Includes charges of $(570)K for the three months ended and $(21,102)K

for the year ended December 31, 2007 related to our completion of the

first step of the two step process under which we acquired

Bioenvision. In July 2007, we acquired approximately 22% of the

outstanding shares of Bioenvision common stock on an as-converted

basis, including all of the outstanding shares of Bioenvision

preferred stock for $(72,229)K of cash. Subsequently, in October

2007, following a favorable merger vote by Bioenvision's

shareholders, we completed the second step of the acquisition and,

effective October 23, 2007, acquired the remaining outstanding shares

of Bioenvision common stock for $(245,055)K of cash. In the fourth

quarter of 2007, we also paid $(11,975)K of cash for the outstanding

options to purchase shares of Bioenvision common stock. The full

purchase accounting for the acquisition of Bioenvision, including the

impact of the second step, is reflected in our consolidated financial

statements for the three months and year ended December 31, 2007 and

as of December 31, 2007.

(8) For the year ended December 31, 2007, includes a pre-tax gain of

$10,848K recorded on the sale of our entire investment in the common

stock of Therapeutic Human Polyclonals Inc. in March 2007, which had

a zero cost basis. For the year ended December 31, 2006, includes

pre- tax gains of $69,359K related to the liquidation
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Loss of ... help explain why many seniors have trouble falling and ... patients, sleep disruption can be especially severe and often ... researchers. The investigators analyzed data from the Rush ... who enrolled at age 65 and are being followed ...
(Date:8/20/2014)... The Board of Directors of top ... is pleased to announce the expansion of its ... and the surrounding region. In support of this ... AIA has relocated to the firm’s office in Shanghai, ... and design and to better support regional clients. ...
(Date:8/20/2014)... Sockeye salmon that sprint to spawning grounds through fast-moving ... University of British Columbia scientists. , When salmon encounter ... downstream of dams they must move upstream using ... to sprinting for humans. , "Days after sockeye passed ... dying only a short distance from their spawning grounds," ...
(Date:8/20/2014)... Research from Columbia University Medical Center shows that nerves ... and that blocking nerve signals using surgery or Botox ... The study was conducted by the laboratory of Timothy ... PhD, in Norway and is published in today,s issue ... long observed that human and mouse cancers contain a ...
(Date:8/20/2014)... Quincy Bioscience, a Wisconsin-based biotech company, has been ... fastest growing private companies in the nation , for ... Bioscience is honored again to be grouped with the ... Bioscience is manufacturer of Prevagen brand supplements, which contain ... in jellyfish and clinically shown to improve memory. Sales ...
Breaking Medicine News(10 mins):Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:Salmon forced to 'sprint' less likely to survive migration 2Health News:Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice 2Health News:Quincy Bioscience Recognized in Inc. 500|5000 List of America’s Fastest Growing Companies for Third Consecutive Year 2
... public sector undertakings and autonomous bodies will give first ... subsidiaries for purchasing 102 medicines for a period of ... the Cabinet, which met here today, the first preference ... their subsidiaries by state governments in their purchases which ...
... of a single ,family. The disease causes severe anxiety// and ... certain behaviors. It is estimated that close relatives of OCD ... ,Now, new research is shedding new light on ... pattern. And while no one gene "causes" OCD, the research ...
... are considering becoming pregnant could prevent preeclampsia if they ... and following it up// during the first three months ... woman’s blood pressure shoots up dangerously and could prove ... University of Pittsburgh say that this condition could be ...
... dependence and abuse can be moderately improved by various ... may be the best clinicians// can hope for at ... ,One-on-one cognitive behavioral therapy (CBT) is most effective, but ... or improve social problems associated with their marijuana use. ...
... According to a study conducted by Linda Chaudron, M.D., an ... the Medical Center// postpartum depression is a disorder which is ... that the women should be screened for a period of ... up is very much essential as the symptoms, develop throughout ...
... the World Organization for Animal Health (OIE) and the ... called the Global Early Warning and Response// System (GLEWS), ... diseases to humans. ,Dr Bernard Vallat, Director ... point of view, controlling contagious animal diseases in their ...
Cached Medicine News:Health News:Obsessive-Compulsive Disorder Is Familial 2Health News:Obsessive-Compulsive Disorder Is Familial 3Health News:Using Multivitamins Before And After Conception Averts Preeclampsia 2Health News:Using Multivitamins Before And After Conception Averts Preeclampsia 3Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 3Health News:Early Diagnosis of Postpartum Depression Is Very Essential Among New Mothers 2
(Date:8/20/2014)... , Aug. 20, 2014 Research and ... Report of Pralmorelin" report to their offering. ... providing comprehensive data on Pralmorelin globally and regionally ( ... North America , Latin America ... Pralmorelin This report focuses on three primary areas; ...
(Date:8/20/2014)... Mass. , Aug. 20, 2014 /PRNewswire/ ... electrophysiology (EP) mapping and ablation device market ... use ablation to treat atrial fibrillation (AF). ... primary treatment option for AF will spur ... this application, such as advanced loop diagnostic ...
(Date:8/20/2014)... -- Glades Drugs, an independent pharmacy chain based out of ... into a new corporate headquarters in Lake Worth, ... and state of the art lab. With this expansion Glades ... the new facility. The newly acquired office ... chain,s corporate headquarters and closed door pharmacy, and is in ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: